7-96171508-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014251.3(SLC25A13):​c.1194A>G​(p.Leu398Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.374 in 1,607,950 control chromosomes in the GnomAD database, including 116,632 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9459 hom., cov: 32)
Exomes 𝑓: 0.38 ( 107173 hom. )

Consequence

SLC25A13
NM_014251.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:10

Conservation

PhyloP100: 0.616

Publications

30 publications found
Variant links:
Genes affected
SLC25A13 (HGNC:10983): (solute carrier family 25 member 13) This gene is a member of the mitochondrial carrier family. The encoded protein contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria. The protein catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane. Mutations in this gene result in citrullinemia, type II. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
SLC25A13 Gene-Disease associations (from GenCC):
  • citrin deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • citrullinemia, type II, adult-onset
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • citrullinemia type II
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • neonatal intrahepatic cholestasis due to citrin deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 7-96171508-T-C is Benign according to our data. Variant chr7-96171508-T-C is described in ClinVar as Benign. ClinVar VariationId is 260370.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.616 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.574 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A13NM_014251.3 linkc.1194A>G p.Leu398Leu synonymous_variant Exon 12 of 18 ENST00000265631.10 NP_055066.1 Q9UJS0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A13ENST00000265631.10 linkc.1194A>G p.Leu398Leu synonymous_variant Exon 12 of 18 1 NM_014251.3 ENSP00000265631.6 Q9UJS0-1

Frequencies

GnomAD3 genomes
AF:
0.344
AC:
52262
AN:
151896
Hom.:
9434
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.255
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.353
Gnomad ASJ
AF:
0.258
Gnomad EAS
AF:
0.591
Gnomad SAS
AF:
0.530
Gnomad FIN
AF:
0.362
Gnomad MID
AF:
0.402
Gnomad NFE
AF:
0.368
Gnomad OTH
AF:
0.355
GnomAD2 exomes
AF:
0.395
AC:
99124
AN:
250830
AF XY:
0.404
show subpopulations
Gnomad AFR exome
AF:
0.251
Gnomad AMR exome
AF:
0.385
Gnomad ASJ exome
AF:
0.266
Gnomad EAS exome
AF:
0.577
Gnomad FIN exome
AF:
0.373
Gnomad NFE exome
AF:
0.369
Gnomad OTH exome
AF:
0.378
GnomAD4 exome
AF:
0.377
AC:
549070
AN:
1455936
Hom.:
107173
Cov.:
33
AF XY:
0.382
AC XY:
276889
AN XY:
724604
show subpopulations
African (AFR)
AF:
0.250
AC:
8338
AN:
33388
American (AMR)
AF:
0.377
AC:
16873
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.264
AC:
6898
AN:
26100
East Asian (EAS)
AF:
0.568
AC:
22511
AN:
39634
South Asian (SAS)
AF:
0.535
AC:
46035
AN:
86110
European-Finnish (FIN)
AF:
0.377
AC:
20101
AN:
53316
Middle Eastern (MID)
AF:
0.414
AC:
2377
AN:
5746
European-Non Finnish (NFE)
AF:
0.364
AC:
403001
AN:
1106760
Other (OTH)
AF:
0.381
AC:
22936
AN:
60170
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
14830
29660
44491
59321
74151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12794
25588
38382
51176
63970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.344
AC:
52317
AN:
152014
Hom.:
9459
Cov.:
32
AF XY:
0.349
AC XY:
25911
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.255
AC:
10571
AN:
41452
American (AMR)
AF:
0.353
AC:
5403
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.258
AC:
896
AN:
3468
East Asian (EAS)
AF:
0.591
AC:
3059
AN:
5172
South Asian (SAS)
AF:
0.530
AC:
2546
AN:
4802
European-Finnish (FIN)
AF:
0.362
AC:
3825
AN:
10554
Middle Eastern (MID)
AF:
0.405
AC:
119
AN:
294
European-Non Finnish (NFE)
AF:
0.368
AC:
25000
AN:
67962
Other (OTH)
AF:
0.362
AC:
765
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1733
3466
5200
6933
8666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.361
Hom.:
45193
Bravo
AF:
0.335
Asia WGS
AF:
0.559
AC:
1944
AN:
3478
EpiCase
AF:
0.361
EpiControl
AF:
0.360

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Allele frequency is common in at least one population database (frequency: 57.961% in ExAC) based on the frequency threshold of 1.504% for this gene. Variant was observed in a homozygous state in population databases more than expected for disease. 4 reputable source/s reports the variant as benign, but the evidence is not available to the laboratory to perform an independent evaluation. A synonymous variant not located in a splice region. -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 07, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neonatal intrahepatic cholestasis due to citrin deficiency Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Citrin deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Citrullinemia type II Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Citrullinemia, type II, adult-onset Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Late-onset citrullinemia Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Citrullinemia type I Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
8.6
DANN
Benign
0.73
PhyloP100
0.62
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2301629; hg19: chr7-95800820; COSMIC: COSV55714080; API